FDA Gets “Interactive” In New Premarket Guidance Document
This article was originally published in The Gray Sheet
Executive Summary
A Dec. 28 final FDA guidance document lays out a path for more informal interaction between agency reviewers and device companies while preserving CDRH's options to place holds on premarket reviews